Pantoloc Indications/Uses





Full Prescribing Info
20 mg: Adults: Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment.
Adults and Adolescents aged 12 years and above: For symptomatic improvement (e.g. heartburn, acid regurgitation, pain in swallowing) and healing of mild reflux esophagitis.
For long term management and prevention of relapse in reflux esophagitis.
Children aged from 5 to 11 years old: Gastro-esophageal reflux disease (GERD), Symptomatic GERD. The treatment of heartburn and other symptoms associated with GERD.
Reflux esophagitis.
The treatment duration should not exceed 8 weeks.
40 mg: Adults: Moderate and severe reflux esophagitis; in combination with two appropriate antibiotics (see Dosage & Administration) for the eradication of H. pylori in patients with peptic ulcers with the objective of reducing the recurrence of duodenal and gastric ulcers caused by this microorganism; duodenal ulcer; gastric ulcer; Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions.
Children aged from 5 to 17 years: Reflux esophagitis.
The treatment duration should not exceed 8 weeks.
IV: Duodenal ulcer; gastric ulcer, moderate and severe reflux esophagitis; Zollinger-Ellison-syndrome and other conditions associated with pathological overproduction of gastric acid; treatment of bleeding peptic ulcer and prevention of re-bleeding; prophylaxis of acute bleeding stress ulcer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in